MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Absence of identifiable neuropathological correlates of cognitive impairment in multiple system atrophy

    S. Radmard, T. Ma, J. Agin-Liebes (Atlanta, USA)

    Objective: To analyze neuropathological correlates of cognitive impairment in multiple system atrophy (MSA) and characterize the affected cognitive domains. Background: Current MSA census criteria delineate…
  • 2025 International Congress

    Metabolic Patterns in Multiple System Atrophy: Brain Network Insights from Spatial ICA of FDG-PET

    J. Li, H. Wang, B. Wang, Z. Cen, W. Luo (Hangzhou, China)

    Objective: This study employs spatial independent component analysis (ICA) on 18F-fluorodeoxyglucose (FDG)-PET imaging to decompose metabolic heterogeneity in Multiple system atrophy (MSA), identifying key brain…
  • 2025 International Congress

    Utilizing the 15-item modification of the PSPRS rating scale (mPSPRS-15) as the primary endpoint for future clinical trials in progressive supranuclear palsy

    F. Nery, T. Nevmyrych, J. Murphy, S. Wu, Y. Zabar, A. Gafson, S. Bullain, J. O’Gorman (Cambridge, USA)

    Objective: To compare the properties of PSPRS-28, mPSPRS-15, and the rPSPRS-10 and assess their utility as a primary endpoint in PSP trials. Background: Progressive supranuclear…
  • 2025 International Congress

    Normal Pressure Hydrocephalus in Vestibular Schwannoma Patients

    T. Davidy, S. Anis, T. Goldberg, A. Fay-Karmon, Y. Zauberman, N. Rennert, O. Lesman-Segev, S. Hassin-Baer (Cleveland, USA)

    Objective: The first objective is to evaluate the potential pathophysiological link between vestibular schwannoma (VS) and normal pressure hydrocephalus (NPH) by analyzing clinical features, imaging…
  • 2025 International Congress

    Novel Multiple System Atrophy Subtypes Identified Using Unsupervised Machine Learning Algorithms

    H. Sekiya, D. Ono, A. Maier, D. Dickson (Jacksonville, USA)

    Objective: To identify a novel disease subtype of multiple system atrophy (MSA) by applying machine learning algorithms to a large cohort of autopsy-confirmed MSA. Background:…
  • 2025 International Congress

    The Radiographic Overlap Between Normal Pressure Hydrocephalus (NPH) and Progressive Supranuclear Palsy (PSP): When Looks Can Be Deceiving

    R. Mani, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)

    Objective: To demonstrate the overlap on radiographic metrics between NPH and PSP. Background: The neuroradiological hallmark of NPH is non-obstructive ventriculomegaly (Evans’ index (EI) >0.3).…
  • 2025 International Congress

    Topographical heterogeneity of cholinergic system status in Multiple System Atrophy: A series report

    A. Narkis, G. Carli, J. Barr, R. Vangel, C. Spears, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)

    Objective: To characterize individual-level topographical patterns of cholinergic upregulation and downregulation in Multiple System Atrophy (MSA) using a whole brain voxel-wise approach. Background: MSA is…
  • 2025 International Congress

    Quantitative Regional Tau Pathology and Spatial Transcriptomics Identify Signatures of Phenotypic Diversity in Progressive Supranuclear Palsy.

    P. Cullinane, J. Parmera, T. Curless, L. Paras Chajed, S. Wrigley, W. Sifontes Valladares, J. Anton Arnal, M. Burrows, K. Ebanks, M. Blunskyte, D. Gavriouchkina, L. Binding, T. Revesz, S. Brandner, A. Young, E. de Pablo-Fernández, H. Morris, Y. Lim, H. Nelvagal, T. Warner, Z. Jaunmuktane (London, United Kingdom)

    Objective: To determine the pathological and molecular determinants of phenotypic diversity in PSP. Background: PSP exhibits broad variability in clinical phenotype and progression, however the…
  • 2025 International Congress

    4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies and CBD from PSP in post-mortem brain samples

    L. de Mena, M. Fernandez, J. Perez, C. Painous, A. Camara, A. Perez-Soriano, L. Molina-Porcel, E. Artikis, B. Caughey, Y. Compta (Barcelona, Spain)

    Objective: To investigate whether 4R-TAU seed amplification assay discriminates tauopathies from non-tauopathies as well as CBD from PSP in post-mortem brain samples. Background: 4 repeat…
  • 2025 International Congress

    Low Level of Serum Total Cholesterol Predicts Mortality in Early-stage Multiple System Atrophy: a Prospective-cohort Study

    JX. Huang, LY. Zhang, QR. Jiang, SC. Wang, Y. Xiao, NN. Che, JY. Lin, B. Zhao, YF. Cheng, CY. Li, HF. Shang (Chengdu, Sichuan, China)

    Objective: The study aims to clarify the association between baseline level of serum TC and survival of patients with early MSA. Background: Serum total cholesterol…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley